ÂÜÀòÂÒÂ×

Eric is currently the Chief Financial Officer of Immunomic Therapeutics, a privately held biotechnology company based in Rockville, MD. He is a 30-year veteran of life sciences companies where he has addressed a wide array of financial issues including raising capital, SEC reporting, investor relations, banking, taxation, mergers and acquisitions, international operations and financial planning, analysis and accounting operations. Eric has helped raise over $1 billion in debt and equity transactions and has served private and public companies ranging from start-ups to operating companies with revenues of $1 billion. Eric’s work experience includes service with OpGen Inc, Avalon Pharmaceuticals, Inc. Invitrogen Corporation, Life Technologies, Inc., and Genex Corporation principally serving as Chief Financial Officer. In addition, Eric serves as a member of the board of directors and Audit Committee Chair for Nuo Therapeutics, Inc.